Quantcast

Latest pharmaceutical industry Stories

2014-09-17 16:27:25

ST. PAUL, Minn., Sept. 17, 2014 /PRNewswire/ -- The United States doesn't have a singular prescription drug problem, we have a series of challenges related to safety, efficacy and cost, according to Peter Wickersham, senior vice president for Integrated Care and Specialty at Prime Therapeutics LLC (Prime). Wickersham will deliver a keynote address, "Solving America's Drug Problem," at the Managed Markets Summit in Scottsdale, Ariz., on Sept. 19, 2014. "Opinions may vary on the causes,...

2014-09-17 12:27:05

New multi-year grant furthers non-profit organization's work to accelerate the drug development process TUCSON, Ariz., Sept. 17, 2014 /PRNewswire-USNewswire/ -- The Critical Path Institute (C-Path) announced today that the U.S. Food and Drug Administration (FDA) has awarded the organization $2.1 million in first year funding of a five-year grant with the potential of $10.5 million over the five years. This is the second five-year grant that C-Path has received from the FDA under the...

2014-09-17 12:27:03

-- Compass(TM) Up for Technology Innovation Award -- NEWTOWN, Pa., Sept. 17, 2014 /PRNewswire/ -- BioClinica®, Inc., a leading provider of outsourced clinical trial services and eClinical Solutions, today announced three of its experts are speaking at the 20th Annual SCDM Conference for Clinical Data Management to be held September 28 to October 1 in Las Vegas, Nevada. The Company also announced the innovative Compass technology, a risk-based monitoring solution to raise overall quality in...

2014-09-17 08:31:00

HAYWARD, Calif., Sept. 17, 2014 /PRNewswire/ -- Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) date for its review of the RYTARY(TM) (IPX066) New Drug Application (NDA) from October 9, 2014, to January 9, 2015. The Company amended the chemical, manufacturing and control (CMC) section of the RYTARY NDA subsequent to...

2014-09-17 08:29:31

- Collaboration and license agreement allows the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, to enhance its access to antibody drug conjugate technologies and to expand its oncology pipeline SAN FRANCISCO, Sept. 17, 2014 /PRNewswire/ -- Sutro Biopharma, a biopharmaceutical company developing antibody drug conjugates and bispecific antibodies, and the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, which operates as EMD Serono in the United States and...

2014-09-16 23:13:20

InTouchMD™ launches innovative social media tool that allows pharmaceutical companies and physicians to better connect with their patients. Garden City, NY (PRWEB) September 16, 2014 InTouchMD, a New York based multi-channel contact center dedicated to serving the healthcare industry, has launched a revolutionary service that gives pharmaceutical companies the ability to connect to their patients through social media in order to foster better patient diagnostics and care. “We have...

2014-09-16 23:12:55

The research team at Avail Clinical is conducting a clinical study to evaluate a new remedy for the common cold. Adults who are experiencing early cold symptoms, but are otherwise healthy, may qualify to participate. DeLand, Florida (PRWEB) September 16, 2014 *Anyone who is interested in learning more about the clinical trials being conducted in DeLand, FL can visit Avail Clinical Research on the web (http://www.availclinical.com/trial/common-cold/) or contact them directly at (386)...

2014-09-16 23:11:40

Achieve Clinical Research is looking for adults who have never have not been vaccinated for pneumonia within the last year to take part in this new clinical study. Applicants should be at least 18 years old in order to qualify for a clinical trial here in Birmingham. Birmingham, Alabama (PRWEB) September 16, 2014 *To find out more about this pneumonia vaccine clinical trial in Birmingham, AL, visit Achieve Clinical Research on the web...

2014-09-16 23:07:50

The CNPR certificate, since its inception of the Fall of 1999, has proven to help entry level applicants understand all of the pharmaceutical industry terms, product knowledge and regulations needed to work as a successful pharmaceutical sales rep. The CNPR program is widely known to help entry level applicants with their knowledge of the industry which then allows them to meet basic pharmaceutical sales job pre-requisites. Washington, DC (PRWEB) September 16, 2014 Building a workforce...

2014-09-16 23:04:40

For the first time, Orange Paper readers will have a detailed snapshot of clinical trials in Ukraine MOSCOW, Russia (PRWEB) September 16, 2014 Synergy Research Group has debuted the Ukraine Orange Paper. The comprehensive report gives the best detail and analysis of the state of clinical trials in Ukraine. Data was pulled from a variety of sources, including Ministry of Health in Ukraine and the FDA, etc. The Ukraine Orange Paper will give readers actionable intelligence on clinical...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.